X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (10890) 10890
Book Review (1112) 1112
Publication (428) 428
Newsletter (263) 263
Conference Proceeding (77) 77
Newspaper Article (45) 45
Book Chapter (23) 23
Magazine Article (21) 21
Dissertation (6) 6
Transcript (4) 4
Government Document (1) 1
Presentation (1) 1
Reference (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (8934) 8934
humans (8162) 8162
female (5052) 5052
male (4581) 4581
melphalan (4393) 4393
middle aged (3873) 3873
melphalan - administration & dosage (3345) 3345
oncology (3267) 3267
adult (2945) 2945
aged (2920) 2920
melphalan - therapeutic use (2792) 2792
hematology (2554) 2554
antineoplastic combined chemotherapy protocols - therapeutic use (2229) 2229
multiple myeloma - drug therapy (1994) 1994
chemotherapy (1940) 1940
animals (1734) 1734
multiple myeloma (1680) 1680
transplantation (1650) 1650
treatment outcome (1549) 1549
combined modality therapy (1253) 1253
cancer (1134) 1134
stem-cell transplantation (1126) 1126
transplantation, autologous (1113) 1113
abridged index medicus (1101) 1101
prognosis (1038) 1038
therapy (1019) 1019
melphalan - adverse effects (1014) 1014
melphalan - pharmacology (979) 979
mice (965) 965
multiple myeloma - therapy (964) 964
immunology (889) 889
cyclophosphamide - administration & dosage (887) 887
survival (886) 886
bortezomib (856) 856
stem cells (847) 847
retrospective studies (821) 821
care and treatment (816) 816
hematopoietic stem cell transplantation (795) 795
adolescent (774) 774
time factors (774) 774
antineoplastic agents - therapeutic use (746) 746
antineoplastic combined chemotherapy protocols - administration & dosage (746) 746
follow-up studies (722) 722
high-dose melphalan (715) 715
aged, 80 and over (712) 712
disease-free survival (704) 704
antineoplastic combined chemotherapy protocols - adverse effects (695) 695
survival analysis (687) 687
multiple myeloma - mortality (683) 683
survival rate (683) 683
dose-response relationship, drug (654) 654
cyclophosphamide (647) 647
drug therapy, combination (645) 645
dexamethasone (643) 643
prednisone - administration & dosage (630) 630
stem cell transplantation (629) 629
research (610) 610
antineoplastic agents, alkylating - administration & dosage (603) 603
prednisone (603) 603
cyclophosphamide - therapeutic use (589) 589
remission induction (567) 567
multiple-myeloma (557) 557
vincristine - administration & dosage (552) 552
child (548) 548
multiple myeloma - pathology (541) 541
doxorubicin - administration & dosage (529) 529
surgery (527) 527
bone-marrow transplantation (523) 523
medicine, general & internal (517) 517
dexamethasone - administration & dosage (514) 514
melanoma - drug therapy (506) 506
thalidomide (505) 505
antineoplastic agents - administration & dosage (489) 489
bone marrow transplantation (482) 482
melanoma (481) 481
antineoplastic agents, alkylating - therapeutic use (472) 472
prednisone - therapeutic use (456) 456
medicine & public health (455) 455
child, preschool (452) 452
analysis (451) 451
trial (446) 446
bone-marrow-transplantation (445) 445
rats (445) 445
amyloidosis (443) 443
recurrence (443) 443
multiple myeloma - complications (441) 441
pharmacology & pharmacy (433) 433
neoplasm staging (432) 432
dosage and administration (430) 430
hematopoietic stem cells (424) 424
carmustine - administration & dosage (421) 421
etoposide - administration & dosage (421) 421
health aspects (420) 420
chemotherapy, cancer, regional perfusion (418) 418
transplantation conditioning - methods (407) 407
hematopoietic stem cell transplantation - methods (397) 397
antineoplastic agents - pharmacology (389) 389
prospective studies (388) 388
drug administration schedule (381) 381
toxicity (381) 381
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9830) 9830
Russian (415) 415
German (262) 262
French (219) 219
Japanese (176) 176
Spanish (92) 92
Italian (73) 73
Chinese (47) 47
Polish (41) 41
Czech (16) 16
Dutch (14) 14
Swedish (10) 10
Hebrew (8) 8
Korean (8) 8
Norwegian (8) 8
Danish (6) 6
Hungarian (6) 6
Slovenian (5) 5
Portuguese (4) 4
Slovak (4) 4
Bulgarian (3) 3
Croatian (3) 3
Finnish (3) 3
Serbian (3) 3
Ukrainian (3) 3
Romanian (2) 2
Turkish (2) 2
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cardiovascular and interventional radiology, ISSN 0174-1551, 12/2017, Volume 40, Issue 12, pp. 1966 - 1966
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s00270-017-1766-2 
Melphalan
Journal Article
La Revue de medecine interne, ISSN 0248-8663, 06/2019, Volume 40, p. A156
La relation entre maladies auto-immunes ou systemiques et cancers n'est pas fortuite et a deja ete decrite. Une pathologie auto-immune peut representer le... 
Cyclophosphamide | Melphalan
Journal Article
Pediatric Blood & Cancer, ISSN 1545-5009, 08/2016, Volume 63, Issue 8, pp. 1349 - 1356
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2014, Volume 371, Issue 10, pp. 906 - 917
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2014, Volume 371, Issue 10, pp. 895 - 905
In patients 65 or younger with multiple myeloma, high-dose consolidation therapy was associated with longer survival and more myelotoxicity than... 
MEDICINE, GENERAL & INTERNAL | PREDNISONE | PLUS DEXAMETHASONE | INDUCTION THERAPY | LENALIDOMIDE | INITIAL TREATMENT | RANDOMIZED CONTROLLED-TRIAL | BORTEZOMIB | STEM-CELL TRANSPLANTATION | ELDERLY-PATIENTS | MELPHALAN | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Multiple Myeloma - mortality | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Transplantation, Autologous | Consolidation Chemotherapy | Antineoplastic Agents, Alkylating - administration & dosage | Thalidomide - analogs & derivatives | Multiple Myeloma - drug therapy | Multiple Myeloma - therapy | Melphalan - adverse effects | Adult | Maintenance Chemotherapy | Neutropenia - chemically induced | Thalidomide - adverse effects | Prednisone - administration & dosage | Prednisone - adverse effects | Kaplan-Meier Estimate | Combined Modality Therapy | Thalidomide - administration & dosage | Disease-Free Survival | Melphalan - administration & dosage | Aged | Antineoplastic Agents, Alkylating - adverse effects | Stem Cell Transplantation - adverse effects | Complications and side effects | Care and treatment | Patient outcomes | Multiple myeloma | Stem cells | Transplantation | Research | Health aspects | Autografts | Chemotherapy | Cell survival | Transplants & implants | Melphalan | Stem cell transplantation | Death | Prednisone | Drug dosages | Neutropenia | Index Medicus | Abridged Index Medicus
Journal Article
British Journal of Clinical Pharmacology, ISSN 0306-5251, 07/2016, Volume 82, Issue 1, pp. 149 - 159
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2008, Volume 359, Issue 9, pp. 906 - 917
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2012, Volume 366, Issue 19, pp. 1759 - 1769
Journal Article
Journal Article